New Tezepelumab Data Continue To Strengthen Profile For A Broad Population Of Severe Asthma PatientsPRNewsWire • 05/13/21
Efficacy Of Repatha® (Evolocumab) Across High-Risk Patient Populations Reinforced At ACC.21PRNewsWire • 05/11/21
Amgen To Present At The 2021 Bank of America Merrill Lynch Healthcare ConferencePRNewsWire • 05/06/21
FDA Accepts Amgen's Supplemental New Drug Application For Otezla® (apremilast) For Adults With Mild-To-Moderate Plaque PsoriasisPRNewsWire • 05/05/21
Is It Time to Buy the Dow Jones Industrials Average's 3 Worst-Performing Stocks of April?The Motley Fool • 05/05/21
Amgen Provides Updated Information On LUMAKRAS™ (Sotorasib)¹ Dose Comparison StudyPRNewsWire • 04/28/21
Amgen Inc. (AMGN) CEO Robert Bradway on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 04/28/21